ClinicalTrials.gg
RecruitingNCT07124494Updated Jul 22, 2026

Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction

An interventional study of Regional anethesia in Total Knee Arthroplasty, Postoperative Pain and Regional Anesthesia, sponsored by Konya City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Konya City Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 22 studies in Pain, Postoperative by Konya City Hospital — 11 open to participants now, 11 under way, none of them phase 3. Pain, Postoperative · Konya City Hospital.

Planned enrollment
18th of 18
30 · median 73
Started
2025
with 8 others
No phase
17 of 22
9 open now
Primary completion
2026-12
later than 4 of 10 live
Registered
10th of 22
by date

Among the 22 studies in Pain, Postoperative by Konya City Hospital, this one is the 18th largest by planned enrollment of the 18 interventional ones that give a count, is one of 9 that started in 2025, is one of 17 with no phase, reaches primary completion later than 4 of the 10 other live ones, and was the 10th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

11 of the 22 studies in Pain, Postoperative by Konya City Hospital are open now, in 1 country. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Pain, Postoperative by Konya City Hospital, or all of them as a file.
02

Study summary

This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia/analgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.

03

Conditions studied

  • Total Knee Arthroplasty
  • Postoperative Pain
  • Regional Anesthesia
  • Knee Range of Motion
  • Patient Satisfaction
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

  • Minimum Age: 18 Years
  • Maximum Age: None
  • Sex: All
  • Gender Based: No
  • Accepts Healthy Volunteers: No

Inclusion criteria

  • Scheduled for primary total knee arthroplasty

    • Age ≥ 18 years
    • (ASA) physical status I-III
    • Accepting neuraxial anesthesia

Exclusion criteria

  • Skin infection at the planned injection site

    • Sepsis
    • Coagulopathy
    • Refusal of neuraxial anesthesia
    • Severe hypovolemia
    • Demyelinating central nervous system disease
    • Age under 18 years
    • Illiterate in Turkish
    • Non-cooperative patients
    • Known allergy or to bupivacaine
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Combined Spinal-Epidural Anesthesia

    Postoperative analgesia will be provided via epidural catheter with programmed infusion of bupivacaine .

    Procedure: Regional anethesia

  • Active comparator
    Adductor Canal Block

    Ultrasound-guided adductor canal catheter placement and continuous infusion of bupivacaine .

    Procedure: Regional anethesia

  • Sham comparator
    Multimodal Intravenous Analgesia

    Continuous intravenous tramadol infusion with rescue analgesia as required.

    Procedure: Regional anethesia

Interventions

  • ProcedureRegional anethesia

    This single-center, prospective, randomized controlled trial aims to compare the effects of three different postoperative analgesia techniques following spinal anesthesia in patients undergoing total knee arthroplasty (TKA). The study will assess the impact of combined spinal-epidural anesthesia, adductor canal block, and multimodal intravenous analgesia on postoperative knee range of motion (ROM). Secondary outcomes include patient satisfaction, opioid consumption, Oxford Knee Score (OKS), activity levels, and visual analog scale (VAS) pain scores.

06

What researchers measure

Primary outcomes

  1. Postoperative Knee Range of Motion (ROM)

    Knee joint flexion and extension range of motion will be measured using a standard goniometer by a blinded assessor. Measurements will be performed with the patient in a supine position, ensuring standardized positioning for all participants.

    Time frame: Postoperative day 1, day 3, day 7, and day 90 after surgery.

Secondary outcomes

  1. Total Opioid Consumption

    Cumulative opioid consumption (intravenous and oral) will be recorded and converted to morphine milligram equivalents (MME).

    Time frame: From the end of surgery to 72 hours postoperatively.

  2. Oxford Knee Score (OKS)

    Oxford Knee Score (OKS) questionnaire: Functional outcome will be evaluated using the Oxford Knee Score, a validated 12-item questionnaire assessing pain and physical function.To assess knee pain and functional ability from the patient's perspective. Number of questions: 12 Score range: 0 to 48 Interpretation: 0 points = worst possible outcome (severe pain and poor function) 48 points = best possible outcome (no pain and full function) Direction: Higher scores indicate better outcomes

    Time frame: Preoperatively (baseline) and postoperative day 90.

  3. Visual Analog Scale (VAS) Pain Score

    Pain intensity at rest and during movement will be assessed using a 10-cm visual analog scale (0 = no pain, 10 = worst possible pain).

    Time frame: Postoperative day 1, day 3, and day 7 after surgery.

  4. Incidence of Adverse Events Related to Anesthesia or Analgesia

    The occurrence of anesthesia- or analgesia-related complications (e.g., motor weakness, sensory deficits, infection at catheter site, nausea/vomiting, hypotension) will be recorded.

    Time frame: Intraoperative period and up to 90 days postoperatively.

  5. Patient Satisfaction Score

    Patient satisfaction with postoperative analgesia will be assessed using a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied).

    Time frame: Postoperative day 3 and day 90 after surgery.

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 16 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 8, 2025
First posted
Aug 15, 2025
StartActual
Aug 5, 2025
Primary completionEst.
Dec 12, 2026
CompletionEst.
Dec 19, 2026
Last update
Jul 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07124494
Lead sponsor
Konya City Hospital
Responsible party
Yasin Tire, MD (Assoc. Prof. Dr. Yasin Tire, Konya City Hospital) — Principal investigator
First posted
Aug 15, 2025
Start date
Aug 5, 2025
Primary completion
Dec 12, 2026 (estimated)
Completion
Dec 19, 2026 (estimated)
Last update
Jul 22, 2026

Study contacts

Yasin Tire
Contact
dryasintire@hotmail.com
05055367970

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion